Aura Biosciences, Inc.

Healthcare · Biotechnology · United States

Last price 6.295 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 652.82M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company’s proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder ...